Berberine Protects Against Dihydrotestosterone-Induced Human Ovarian Granulosa Cell Injury and Ferroptosis by Regulating the Circ_0097636/MiR-186-5p/SIRT3 Pathway

Overview

Journal Appl Biochem Biotechnol

Specialties Biochemistry
Biotechnology

Date 2023 Dec 28

PMID 38153651

Authors

Suqin Wang

Yingfang Wang

Qin Qin

Jianfang Li

Qiaoyun Chen

Ye Zhang

Xiuqing Li

Jianrong Liu

Affiliations

Soon will be listed here.

Abstract

Polycystic ovarian syndrome (PCOS) is an endocrine syndrome in women of reproductive age. Berberine (BBR) is a Chinese herbal monomer that exhibits many pharmacological properties related to PCOS treatment. This study aims to analyze the effect of BBR on a cell model of PCOS and the underlying mechanism. Human ovarian granulosa (KGN) cells were treated with dihydrotestosterone (DHT) to mimic a PCOS cell model. The RNA expression of circ_0097636, miR-186-5p, and sirtuin3 (SIRT3) was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Protein expression was detected by western blotting. Cell viability was analyzed by CCK-8 assay. Cell proliferation and apoptosis were investigated by 5-ethynyl-2'-deoxyuridine (EdU) assay and flow cytometry assay, respectively. The levels of interleukin-6 (IL-6), IL-1β, and tumor necrosis factor-α (TNF-α) were analyzed by enzyme-linked immunosorbent assays (ELISAs). Fe concentration was assessed by an iron assay kit. Oxidative stress was assessed by detecting reactive oxygen species (ROS) level and malondialdehyde (MDA) level using commercial kits. The association of miR-186-5p with circ_0097636 and SIRT3 was identified by dual-luciferase reporter assay and RNA pull-down assay. Circ_0097636 expression was downregulated in the follicular fluid of PCOS patients and DHT-treated KGN cells when compared with control groups. BBR treatment partially relieved the DHT-induced inhibitory effect on cell proliferation and promoted effects on cell apoptosis, inflammation, ferroptosis, and oxidative stress in KGN cells. Additionally, circ_0097636 bound to miR-186-5p, and SIRT3 was identified as a target gene of miR-186-5p in KGN cells. BBR treatment ameliorated DHT-induced KGN cell injury by upregulating circ_0097636 and SIRT3 expression and downregulating miR-186-5p expression. Moreover, circ_0097636 overexpression protected KGN cells from DHT-induced injury by increasing SIRT3 expression. BBR ameliorated DHT-induced KGN cell injury and ferroptosis by regulating the circ_0097636/miR-186-5p/SIRT3 pathway.

Citing Articles

Ferroptosis in diabetic cardiomyopathy: from its mechanisms to therapeutic strategies.

Tian M, Huang X, Li M, Lou P, Ma H, Jiang X Front Endocrinol (Lausanne). 2024; 15:1421838.

PMID: 39588340 PMC: 11586197. DOI: 10.3389/fendo.2024.1421838.

References

Ganie M, Vasudevan V, Wani I, Baba M, Arif T, Rashid A . Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019; 150(4):333-344. PMC: 6902362. DOI: 10.4103/ijmr.IJMR_1937_17. View

Aversa A, La Vignera S, Rago R, Gambineri A, Nappi R, Calogero A . Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions. Front Endocrinol (Lausanne). 2020; 11:516. PMC: 7431619. DOI: 10.3389/fendo.2020.00516. View

Palomba S, Santagni S, Falbo A, La Sala G . Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 2015; 7:745-63. PMC: 4527566. DOI: 10.2147/IJWH.S70314. View

Wang J, Wu D, Guo H, Li M . Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sci. 2019; 236:116940. DOI: 10.1016/j.lfs.2019.116940. View

Ramezani Tehrani F, Amiri M . Polycystic Ovary Syndrome in Adolescents: Challenges in Diagnosis and Treatment. Int J Endocrinol Metab. 2019; 17(3):e91554. PMC: 6679603. DOI: 10.5812/ijem.91554. View

Wang K, Feng X, Chai L, Cao S, Qiu F . The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 2017; 49(2):139-157. DOI: 10.1080/03602532.2017.1306544. View

Rondanelli M, Infantino V, Riva A, Petrangolini G, Faliva M, Peroni G . Polycystic ovary syndrome management: a review of the possible amazing role of berberine. Arch Gynecol Obstet. 2020; 301(1):53-60. PMC: 7028834. DOI: 10.1007/s00404-020-05450-4. View

Zhou W, Cai Z, Liu J, Wang D, Ju H, Xu R . Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020; 19(1):172. PMC: 7734744. DOI: 10.1186/s12943-020-01286-3. View

Wang Y, Mo Y, Peng M, Zhang S, Gong Z, Yan Q . The influence of circular RNAs on autophagy and disease progression. Autophagy. 2021; 18(2):240-253. PMC: 8942425. DOI: 10.1080/15548627.2021.1917131. View

10.

Mu L, Sun X, Tu M, Zhang D . Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2021; 19(1):10. PMC: 7807442. DOI: 10.1186/s12958-020-00687-9. View

11.

Chen A, Jin R, Zhou W, Ye Y, Lu J, Ren Y . CircRNA circ_0043533 facilitates cell growth in polycystic ovary syndrome by targeting miR-1179. Reprod Biol. 2022; 22(2):100637. DOI: 10.1016/j.repbio.2022.100637. View

12.

Lu X, Gao H, Zhu B, Lin G . Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p/ axis. Bioengineered. 2021; 12(1):6748-6758. PMC: 8806864. DOI: 10.1080/21655979.2021.1964157. View

13.

Ma Z, Zhao H, Zhang Y, Liu X, Hao C . Novel circular RNA expression in the cumulus cells of patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2019; 299(6):1715-1725. DOI: 10.1007/s00404-019-05122-y. View

14.

Wang T, Liu Y, Lv M, Xing Q, Zhang Z, He X . miR-323-3p regulates the steroidogenesis and cell apoptosis in polycystic ovary syndrome (PCOS) by targeting IGF-1. Gene. 2018; 683:87-100. DOI: 10.1016/j.gene.2018.10.006. View

15.

Zhang F, Ma T, Cui P, Tamadon A, He S, Huo C . Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine. Front Microbiol. 2019; 10:175. PMC: 6375883. DOI: 10.3389/fmicb.2019.00175. View

16.

Wang Z, Nie K, Su H, Tang Y, Wang H, Xu X . Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome. Phytomedicine. 2021; 91:153654. DOI: 10.1016/j.phymed.2021.153654. View

17.

Shen H, Xu X, Li X . Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis. Reprod Biol Endocrinol. 2021; 19(1):3. PMC: 7789273. DOI: 10.1186/s12958-020-00684-y. View

18.

Shen H, Xu X, Ye D, Li X . Berberine Improves the Symptoms of DHEA-Induced PCOS Rats by Regulating Gut Microbiotas and Metabolites. Gynecol Obstet Invest. 2021; 86(4):388-397. DOI: 10.1159/000518040. View

19.

Zhang J, Ding N, Xin W, Yang X, Wang F . Quantitative Proteomics Reveals That a Prognostic Signature of the Endometrium of the Polycystic Ovary Syndrome Women Based on Ferroptosis Proteins. Front Endocrinol (Lausanne). 2022; 13:871945. PMC: 9330063. DOI: 10.3389/fendo.2022.871945. View

20.

Javadi M, Soleimani Rad J, Gholami Farashah M, Roshangar L . An Insight on the Role of Altered Function and Expression of Exosomes and MicroRNAs in Female Reproductive Diseases. Reprod Sci. 2021; 29(5):1395-1407. DOI: 10.1007/s43032-021-00556-9. View